Interactions of bosutinib with drug transporters: In vitro and In vivo inhibition of organic cation transporter 2, multidrug and toxin extrusion protein 1, and breast cancer resistance protein by bosutinib

Author:

Kang Min-Ji,Kim Min Ju,Seol Yunjin,Chang Ji-Eun,Lee Kyeong-Ryoon,Chae Yoon-JeeORCID

Publisher

Elsevier BV

Reference31 articles.

1. US Food and Drug Administration, Guidance for industry: In vitro drug interaction studies - Cytochrome P450 enzyme and transporter mediated drug interactions, (2020). 〈https://www.fda.gov/media/134582/download〉 (accessed November 11, 2024).

2. US Food and Drug Administration, Guidance for industry: Clinical drug interaction studies - Cytochrome P450 enzyme- and transporter-mediated drug interactions, (2020). https://www.fda.gov/media/134581/download (Accessed November 11, 2024)..

3. Membrane transporters in drug development;Giacomini;Nat. Rev. Drug Discov.,2010

4. Renal drug transporters and their significance in drug–drug interactions;Yin;Acta Pharm. Sin. B.,2016

5. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview;Schinkel;Adv. Drug Deliv. Rev.,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3